Evaxion AS (EVAX)
3.13
+0.03
(+0.97%)
USD |
NASDAQ |
Sep 11, 16:00
3.17
+0.04
(+1.28%)
After-Hours: 20:00
Evaxion Enterprise Value : 19.21M for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 19.21M |
| September 10, 2026 | 18.96M |
| September 09, 2026 | 20.54M |
| September 08, 2026 | 19.54M |
| September 04, 2026 | 19.13M |
| September 03, 2026 | 18.79M |
| September 02, 2026 | 18.71M |
| September 01, 2026 | 17.96M |
| August 31, 2026 | 18.13M |
| August 28, 2026 | 18.21M |
| August 27, 2026 | 19.38M |
| August 26, 2026 | 20.13M |
| August 25, 2026 | 21.04M |
| August 24, 2026 | 21.46M |
| August 21, 2026 | 20.71M |
| August 20, 2026 | 20.46M |
| August 19, 2026 | 19.38M |
| August 18, 2026 | 19.38M |
| August 17, 2026 | 19.21M |
| August 14, 2026 | 20.96M |
| August 13, 2026 | 19.88M |
| August 12, 2026 | 18.71M |
| August 11, 2026 | 18.63M |
| August 10, 2026 | 18.54M |
| August 07, 2026 | 18.96M |
| Date | Value |
|---|---|
| August 06, 2026 | 18.08M |
| August 05, 2026 | 17.96M |
| August 04, 2026 | 17.71M |
| August 03, 2026 | 16.37M |
| July 31, 2026 | 16.62M |
| July 30, 2026 | 16.71M |
| July 29, 2026 | 16.79M |
| July 28, 2026 | 16.46M |
| July 27, 2026 | 17.21M |
| July 24, 2026 | 17.79M |
| July 23, 2026 | 18.54M |
| July 22, 2026 | 18.46M |
| July 21, 2026 | 18.29M |
| July 20, 2026 | 17.63M |
| July 17, 2026 | 18.75M |
| July 16, 2026 | 19.13M |
| July 15, 2026 | 18.54M |
| July 14, 2026 | 18.38M |
| July 13, 2026 | 18.29M |
| July 10, 2026 | 19.54M |
| July 09, 2026 | 19.79M |
| July 08, 2026 | 20.21M |
| July 07, 2026 | 20.71M |
| July 06, 2026 | 21.30M |
| July 02, 2026 | 21.55M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Autolus Therapeutics Plc | 665.07M |
| DBV Technologies SA | 488.42M |
| Cellectis SA | 249.60M |
| Akari Therapeutics Plc | 12.72M |
| Ascendis Pharma A/S | 16.89B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.724M |
| Total Expenses (Quarterly) | 3.724M |
| EPS Diluted (Quarterly) | -0.4464 |
| Earnings Yield | -33.66% |
| Normalized Earnings Yield | -33.82 |